Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Carbon will be King! Voyageur will be first, not last.

<< Previous

Bullboard Posts

Next >>

Post by biggdoggon Jan 23, 2024 1:26pm

177 Views

Post# 35841210

Carbon will be King! Voyageur will be first, not last.

Dwayne Dreger, Global Managing Partner at Rain Cage Carbon, offers: “Rain Cage Carbon intends to be one of the largest providers of the highest value – and physically verified – carbon offsets in the world within the next 5 years.
https://www.einpresswire.com/article/683067910/esg1-announces-blockchain-infrastructure-and-tokenization-partnership-with-rain-cage-carbon

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project